Memorial Sloan Kettering Cancer Center Onco-Nephrology Symposium 2024
The 2024 Onco-Nephrology Symposium welcomes all members of the healthcare team who manage patients with both cancer and kidney disease. This year’s program embraces the multidisciplinary nature of onco-nephrology and features experts in plasma cell disorders such as multiple myeloma, amyloidosis, monoclonal gammopathies as well as renowned speakers on CAR T cell, other biologic therapies, thrombotic microangiopathy, and cardio-renal syndromes. The goal of this forum is to allow academicians, clinicians, and clinical experts to have personal exchanges and robust discussions in order to enhance the clinical experiences and outcomes of patients.
The target audience for this program includes physicians, advanced practice providers, nurses, medical students, and other healthcare professionals interested in the care of cancer patients with kidney disease. This symposium offers attendees the option to participate either in person at Memorial Sloan Kettering’s Zuckerman Research Center (417 East 68th Street, New York City) or virtually via Zoom.
- Outline a comprehensive assessment and treatment of thrombotic microangiopathy
- Strategize a treatment plan for the patient with MGRS as part of a multidisciplinary team
- Effectively utilize novel diagnostic techniques to diagnose monoclonal disorders
- Recognize renal and non-renal toxicities of modern cancer therapy
- Formulate an treatment plan for kidney transplant patients who receive CAR T cell therapy
- Assimilate genetic testing data in the evaluation of thrombotic microangiopathy
- Review assessment and management of glomerular disorders in cancer patients
- Apprehend modern therapeutic approaches to small renal masses and cancers of the kidney
Price : $ 70
